Books

The Defense of the Mieza Compound

 

By Robert Cantrell, Duncan Bucknell, Lee Caffin
Published November 2011

Paperback / Kindle

The differences between winning and losing intellectual property strategies are often subtle. Adopted best practices often only establish a place in the contest. Actually winning can take much more. Join the new Head of IP at Mieza Therapeutics as he seeks to defend Mieza Therapeutic’s new compound, a combination product that promises revolutionary treatment for Idiopathic Pneumonia. Through a series of IP strategy war games disguised as dreams he learns that patents alone will not win the day and that often the best defense needs a good offense as well. The Defense of the Mieza Compound is the second in a series of IP strategy books written by Think IP Strategy. This book focuses on the protection and exploitation of IP in Life Sciences. The first edition (The Defense of the Mieza HChip) was focused on the Tech industry. Additional titles in the series will address manufacturing, entertainment, consumer products, and other industries.

The Defense of the Mieza HChip

 

By Robert Cantrell, Duncan Bucknell
Published November 2011

Paperback  /  Kindle

The difference between winning and losing intellectual property strategies are often subtle. Adopted best practices often only establish a place in the contest. Actually winning can take much more. Join the new Head of IP at Mieza Technologies as he seeks to defend Mieza Technology’s horse chip, an artificial intelligence device that allows automobiles to override driver commands that would otherwise cause accidents. Through a series of IP strategy war games disguised as dreams he learns that patents alone will not win the day and that often the best defense needs a good offense as well. The Defense of the Mieza HChip is the first in a series of IP strategy books written by Think IP Strategy. This book focuses on the protection and exploitation of IP in hi-tech. Additional titles in the series will address life sciences, entertainment, consumer products, and other industries.

Pharmaceutical, Biotechnology and Chemical Inventions: world protection, exploitation and enforcement

 

Edited by Duncan Bucknell
Published April 2011

This book highlights the special issues arising in obtaining, commercialising, enforcing or attacking intellectual property rights (including protection of regulatory data) in the pharmaceutical, biotechnology and chemical industries across the world’s key jurisdictions. It is unique in presenting topic matter horizontally by subject to facilitate comparison between country practices.

The first two chapters give a general introduction to the differences between the jurisdictions and an overview of some of the key concepts in patent law. The remainder of the book is dedicated to a detailed analysis of the major legal issues arising in these areas of technology. Each component chapter has a comparative introduction, looking at the variances in the laws of different domains, followed by side-by-side analysis of the relevant regimes, including tables and flow-charts which summarise and explain the key legal concepts. The jurisdictions covered are the United States, Europe (UK, Germany, Netherlands, France and Italy), Japan, Canada, Australia, India and China.

Readership: Patent agents, patent attorneys, solicitors and barristers working in patent and intellectual property law worldwide. Scientists, researchers and managers in the chemicals, pharmaceuticals and biotechnology industries.

Outpacing the Competition: Patent-Based Business Strategy

Outpacing the Competition: Patent-Based Business Strategy

By Robert L. Cantrell
Published March 2009

Hardcover  / eBook

“Outpacing the Competition provides a useful IP management framework for rapidly evolving and inherently unpredictable R&D environments where companies are partners, customers, and competitors at the same time.” –Marshall Phelps, Corporate Vice President for IP Policy & Strategy, Microsoft

“Robert Cantrell’s book Outpacing the Competition: Patent-Based Business Strategy?should be read by?anyone?involved in the practice of litigating or licensing patent rights or policymakers responsible for patent issues. Mr. Cantrell provides a cogent approach for applying decisional methodology and game theory to enhance the utilization and understanding of patent rights.”–Bradley J. Olson, Esq., patent attorney, Washington, DC

“Robert Cantrell makes a compelling case for using intellectual property as a core for building solid business strategy. He provides a unique and valuable perspective on competitive advantage, as delivered through patent-based business strategy. This is an excellent addition to anyone’s business strategy arsenal.” –Jeff Hovis, Managing Principal, Product Genesis, Innovation Genesis LLC

“Robert truly treats patents and related intellectual property as both a weapon and a shield to help the reader use patents to out-maneuver global competitors of all kinds—the low-cost producer, the high-end innovator, etc. CEOs, attorneys, business and engineering professionals and the like will enjoy the military imagery and flavor provided by Robert. Thanks for clarifying how critical it is to have an understanding of patents in running a truly competitive global business today.” –José W. Jimenez, Esq., Chief Intellectual Property Officer,AMS Research Corporation

Understanding Sun Tzu on the Art of War

Understanding Sun Tzu on the Art of War

By Robert L. Cantrell
Published July 2004

Understanding Sun Tzu on the Art of War is both an interpretation and a source of Sun Tzu’s Art of War that clarifies Sun Tzu’s philosophies on war without compromising the subtlety of thought needed to master them.    It contains a complete translation of Sun Tzu’s Art of War plus an extensive interpretation of Sun Tzu’s Art of War designed to make Sun Tzu’s ideas useful.

Understanding Sun Tzu on the Art of War is in use by the National Defense University and the U.S. Naval War College as a text for senior military officers.  It has proven exceptionally popular with the military in the Washington D.C. and Northern Virginia area, in the civilian high tech centers of Silicon Valley, and in San Diego.